Therefore, inhibiting NCAPG function represents a new strategy worthy of exploring to treat HCC because it could potentially offer a high degree of tumor specificity and few side effects in other tissues with the proper delivery methods. The gene discussed is NCAPG; the disease is hepatocellular carcinoma.